| mRNA |
AM-580 |
CTRPv2 |
pan-cancer |
AAC |
0.0062 |
0.9 |
| mRNA |
T0901317 |
GDSC1000 |
pan-cancer |
AAC |
-0.0053 |
0.9 |
| mRNA |
Erlotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.0079 |
0.9 |
| mRNA |
Sorafenib |
FIMM |
pan-cancer |
AAC |
0.028 |
0.9 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0056 |
0.9 |
| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0054 |
0.9 |
| mRNA |
BRD-K51831558 |
CTRPv2 |
pan-cancer |
AAC |
0.0083 |
0.9 |
| mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
0.0074 |
0.9 |
| mRNA |
Elesclomol |
GDSC1000 |
pan-cancer |
AAC |
0.005 |
0.9 |
| mRNA |
importazole |
CTRPv2 |
pan-cancer |
AAC |
-0.0058 |
0.9 |